A Review on Stem Cells and Their Applications

Authors

  • Raxit Tyagi Student
  • Akshaya Prakash
  • Shishir Tyagi
  • Surya Prakash D.V.

Keywords:

Stem cell, cancer, drug, therapy, regenerative medicine

Abstract

Stem cells have a broad range of spectrum to develop into a diverse range of specialized cell types, showing great potential for transforming medical therapies. These undifferentiated cells have the amazing capacity to replace, regenerate, and heal harmed or ill tissues within the human body. Despite the significant progress made in stem cell research, obstacles such as ethical issues, immune rejection, and tumorigenicity demand ongoing research and strict protocols for use in therapies that require stem cells. Stem cell research, which is still in its infancy, has the potential to greatly improve human health and radically alter how we approach and treat a number of medical illnesses. The present paper presented an outlook on the different properties of stem cell which play an effective role in modern medicine such as cancer studies, immunotherapy, and drug delivery.

References

Zhang CL, Huang T, Wu BL, He WX, Liu D. Stem cells in cancer therapy: opportunities and challenges. Oncotarget. 2017; 8(43): 75756-75766.

Basiri A, Mansouri F, Azari A, Rangbarwan P, Zaraein F, Heidari A, Golchin A. Stem Cell Therapy Potency in Personalizing Severe COVID-19 Treatment. Stem Cell Rev and Rep. 2021; 17: 193–213p.

Tran C, Damaser MS. Stem cells as drug delivery methods: Application of stem cell secretome for regeneration. Advanced Drug Delivery Reviews. 2015; 82: 1–11p.

Rowe R, Daley G, George Q. Induced pluripotent stem cells in disease modelling and drug discovery. Nature Reviews Genetics. 2019; 20(7): 377–388p.

Aly RM. Current state of stem cell-based therapies: an overview. Stem Cell Investig. 2020; 15: 7–8p.

Pérez López S, Otero Hernández J. Advances in stem cell therapy. Adv Exp Med Biol. 2012; 741:

–313p.

Nevala-Plagemann C, Lee C, Tolar J. Placenta-based therapies for the treatment of epidermolysisbullosa. Cytotherapy. 2015; 17(6): 786–795p.

Koç ON, Lazarus HM. Mesenchymal stem cells: Heading into the clinic. Bone Marrow Transplant.

; 27: 235–239p.

Vijayakumar S, Sala R, Kang G, Chen A, Pablo MA, Adebayo AI, Cipriano A, Fowler JL, Gomes DL, Ang LT, Loh KM, Sebastiano V. Monolayer platform to generate and purify primordial germ-like cells in vitro provides insights into human germline specification. Nat Commun. 2023; 14(1):5690p.

Rocha V, Wagner JE, Sobocinski KA, Klein JP, Zhang MJ, Horowitz MM, Gluckman E. Graft-versus-host disease in children who have received a cord-blood or bone marrow transplant from an HLA-identical sibling. Eurocord and International Bone Marrow Transplant Registry Working Committee on Alternative Donor and Stem Cell Sources. N Engl J Med. 2000; 22: 1846–1854p.

Kolios G, Moodley Y. Introduction to Stem Cells and Regenerative Medicine. Respiration. 2013; 85(1): 3–10p.

Song CG, Zhang YZ, Wu HN, Cao XL, Guo CJ, Li YQ, Zheng MH, Han H. Stem cells: a promising candidate to treat neurological disorders. Neural Regen Res. 2018; 13(7): 1294–1298p.

Muniyandi P, O'Hern C, Popa MA, Aguirre A. Biotechnological advances and applications of human pluripotent stem cell-derived heart models. Front Bioeng Biotechnol. 2023; 11: 1–15p.

Zhao D, Lei W, Hu S. Cardiac organoid — A promising perspective of preclinical model. Stem Cell Res Ther. 2021; 12: 272–310p.

Downloads

Published

2023-11-14

Issue

Vol. 13 No. 2 (2023)

Section

Review Article

License

Declaration and Copyright Transfer Form

(to be completed by authors)

I/ We, the undersigned author(s) of the submitted manuscript, hereby declare, that the above manuscript which is submitted for publication in the STM Journals(s), is not published already in part or whole (except in the form of abstract) in any journal or magazine for private or public circulation, and, is not under consideration of publication elsewhere.

  • I/We will not withdraw the manuscript after 1 week of submission as I have read the Author Guidelines and will adhere to the guidelines.
  • I/We Author(s ) have niether given nor will give this manuscript elsewhere for publishing after submitting in STM Journal(s).
  • I/ We have read the original version of the manuscript and am/ are responsible for the thought contents embodied in it. The work dealt in the manuscript is my/ our own, and my/ our individual contribution to this work is significant enough to qualify for authorship.
  •  I/We also agree to the authorship of the article in the following order:

Author’s name                                    

 

1. ________________

2. ________________

3. ________________

4. ________________

 

We  Author(s) tick this box and would request you to consider it as our signature as we agree to the terms of this Copyright Notice, which will apply to this submission if and when it is published by this journal.